⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
La FDA aprueba Mounjaro (tirzepatida) de Lilly para reducir el riesgo cardiovascular en adultos con diabetes tipo 2
prnewswire.com
LLY
FDA approves Lilly's Mounjaro (tirzepatide) to reduce cardiovascular risk in adults with type 2 diabetes
prnewswire.com
LLY
Cytotoxic Drugs Market Report Now Available — Forecasts Market Growth from $16.21B (2026) to $21.06B by 2031, Profiling Pfizer, Roche, Novartis, AstraZeneca, Sanofi, and 15 Other Key Players
globenewswire.com
PFE
NVS
AZN
SNY
LLY
JNJ
MRK
AMGN
BIIB
GILD
BMY
ABBV
XRAY
VTRS
TEVA
SUN
Breast Cancer Continues to Impact Communities; Milwaukee Rallies Together to Take Action at Susan G. Komen® MORE THAN PINK Walk
businesswire.com
FOX
PEP
BAC
LLY
NVS
NTRA
Breast Cancer Continues to Impact Communities; Northwest Ohio Rallies Together to Take Action at Susan G. Komen ® Race for the Cure
businesswire.com
AMZN
LLY
GH
BNTX
BAC
NTRA
Global CD70-Targeting Therapies Market Report 2026 - Highlights Clinical Innovation, Pipeline Trends and Commercial Opportunities
globenewswire.com
ALLO
CRSP
JNJ
PFE
ADCT
REGN
MRNA
BMY
GILD
AMGN
BIIB
AZN
NVS
LLY
ABBV
Global Cancer Peptide Drug Market Report 2026: Opportunities, Approved Drug Dosage, Price, Sales & Clinical Trials Insights to 2031
globenewswire.com
LLY
NVS
AVTX
T. ROWE PRICE EXPLORES WHAT INVESTORS CAN LEARN FROM HONEYWELL TECHNOLOGIES' TRANSFORMATION AND THE FUTURE OF INDUSTRIAL AUTOMATION
prnewswire.com
TROW
HON
GE
NYT
ISRG
NVDA
XOM
C
LLY
TMUS
F
NOC
GS
INTC
HLT
Global Heart Failure Drugs Market to Reach $12.31 Billion by 2035 as Advanced Therapies Reshape Treatment - Industry Analysis and Sales Forecast (2026-2035)
globenewswire.com
AZN
BMY
LLY
NVO
Blood Cancer Therapeutics Market to Reach $125.5 Billion by 2030, Driven by Precision Medicine Advances and Expanding Immunotherapy Pipelines
globenewswire.com
ABBV
AMGN
AZN
BMY
ROG
GILD
GSK
JNJ
LLY
MRK
NVS
SNY
PFE
JAZZ
AMRX